In 2024, the dermatology devices market in North America was characterized by solid growth due to technological advances and increased awareness of skin conditions. Significant drivers of this market included rising demand from a growing population suffering from skin disorders such as acne, dermatitis, and psoriasis. Regulatory policies favoring early detection of skin cancer also boosted the demand for dermatology devices both in clinics and hospitals. Furthermore, investment in R&D by key market players in the U.S., Canada, and Mexico led to advancements in dermatological device-based treatments, attracting a larger patient demographic.
Trends included a shift in consumer preference towards less invasive diagnostic methods and therapeutic treatments. Technological enhancements in laser treatments also gained substantial momentum. Direct-to-consumer marketing of skin care devices witnessed significant growth, predominantly in the U.S., indicating a shift in channels. Moreover, the formation of alliances and mergers among enterprises operating in this sector became commonplace, aimed to bolster their product portfolio and expanding patient outreach. The enforcement of stringent regulatory policies, especially by the FDA, had a major impact on the standardization of dermatology devices across the region.,Key customers included hospitals, dermatology clinics, and research institutes, while some consumers were also purchasing devices for personal use. The hospitality industry, particularly wellness spas and beauty salons, also purchased these devices, contributing to the market growth in North America.
